This inventor holds 1 USPTO granted patent. Top assignee: Indiana University. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Innovations in Proton Beam Measurement by Mark Wolanski
Introduction
Mark Wolanski is an accomplished inventor based in Indianapolis, IN (US). He has made significant contributions to the field of clinical proton therapy through his innovative patent. His work focuses on enhancing the accuracy and efficiency of dose profile measurements in proton fields.
Latest Patents
Mark Wolanski holds a patent for a "Dose profile measurement system for clinical proton fields." This invention features a beam profile measurement detector designed to verify dose distributions created with active methods of clinical proton beam delivery. The system includes a Multi-Pad Ionization Chamber (MPIC) with 128 ionization chambers arranged in one plane, capable of measuring lateral profiles in fields up to 38 cm in diameter. The MPIC pads are designed with a 5 mm pitch for fields up to 20 cm in diameter and a 7 mm pitch for larger fields, achieving an accuracy of field size determination of about 0.5 mm. Additionally, the Multi-Layer Ionization Chamber (MLIC) detector contains 122 small-volume ionization chambers stacked at a 1.82 mm step for depth-dose profile measurements. The MLIC can measure profiles up to 20 cm in depth and determine the 80% distal dose fall-off with approximately 0.1 mm precision. Both detectors can be connected to the same set of electronics modules, forming a comprehensive data acquisition system.
Career Highlights
Mark Wolanski is affiliated with Indiana University, where he continues to advance research in proton therapy. His innovative approach to dose measurement has positioned him as a key figure in the field, contributing to improved patient outcomes in clinical settings.
Collaborations
Mark has collaborated with notable colleagues, including Alan Eads and Dmitri Nichiporov. Their combined expertise enhances the development and application of advanced measurement systems in clinical environments.
Conclusion
Mark Wolanski's contributions to the field of clinical proton therapy through his innovative patent demonstrate his commitment to improving medical technology. His work not only advances scientific understanding but also has the potential to significantly impact patient care in oncology.